title: The behavior after intravenous injection in mice of multiwalled carbon nanotube / Fe3O4 hybrid MRI contrast agents.
abstract: Fe(3)O(4) nanoparticles were in situ loaded on the surface of multiwalled carbon nanotubes (MWCNTs) by a solvothermal method using diethylene glycol and diethanolamine as solvents and complexing agents. The as-prepared MWCNT/Fe(3)O(4) hybrids exhibited excellent hydrophilicity, superparamagnetic property at room temperature, and a high T(2) relaxivity of 175.5 mM(-1) s(-1) in aqueous solutions. In vitro experiments revealed that MWCNT/Fe(3)O(4) had an excellent magnetic resonance imaging (MRI) enhancement effect on cancer cells, and importantly, they displayed low cytotoxicity and neglectable hemolytic activity. After intravenous administration, the T(2)-weighted MRI signal in the liver and spleen of mice decreased significantly, suggesting the potential application of the hybrids as MRI contrast agents. The organ biodistribution studies, histological analyses and elimination investigations showed that the hybrids were uptaken by the liver, lung and spleen after intravenous injection, and could be excreted from the liver and kidney.
authors: The Key Laboratory of Resource Chemistry of Ministry of Education, College of Life and Environmental Science, Shanghai Normal University, 100 Guilin Road, Shanghai 200234, PR China.
authors: Huixia
authors: H
authors: Wu
authors: Gang
authors: G
authors: Liu
authors: Yeming
authors: Y
authors: Zhuang
authors: Dongmei
authors: D
authors: Wu
authors: Haoqiang
authors: H
authors: Zhang
authors: Hong
authors: H
authors: Yang
authors: He
authors: H
authors: Hu
authors: Shiping
authors: S
authors: Yang
mesh_terms: D000818:Animals; D001672:Biocompatible Materials / Q000008:administration & dosage / Q000737:chemistry / Q000378:metabolism; D003287:Contrast Media / Q000008:administration & dosage / Q000737:chemistry* / Q000378:metabolism; D005290:Ferric Compounds / Q000008:administration & dosage* / Q000737:chemistry* / Q000378:metabolism; D006801:Humans; D007275:Injections, Intravenous; D008279:Magnetic Resonance Imaging / Q000379:methods*; D008422:Materials Testing; D051379:Mice; D053758:Nanoparticles / Q000008:administration & dosage / Q000737:chemistry*; D037742:Nanotubes, Carbon / Q000737:chemistry*; D014018:Tissue Distribution
chemical_list: D001672:Biocompatible Materials; D003287:Contrast Media; D005290:Ferric Compounds; D037742:Nanotubes, Carbon; C000499:ferric oxide